A comparative study of the recent most potent small-molecule PD-L1 inhibitors: what can we learn?
Sign Up to like & getrecommendations! Published in 2021 at "Medicinal Chemistry Research"
DOI: 10.1007/s00044-021-02728-3
Abstract: Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have become a “game-changer” in the cancer treatment. However, none of the small molecular inhibitors has been approved yet. To explore the advantages and disadvantages of various scaffolds,… read more here.
Keywords: incyte 011; study recent; comparative study; potent small ... See more keywords